The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common shares of Circle Internet Group, Inc... Show more
CRCA seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Class A common shares of Circle Internet Group (CRCL). Launched in August 2025, it is the first single-stock leveraged ETF tied to Circle, the issuer of the USDC stablecoin. Rather than holding a diversified basket of stocks, the fund uses a single-issuer strategy built primarily on financial instruments and swap exposure designed to deliver its daily 2x objective.
Because CRCA concentrates on one underlying company, its sector allocation is effectively 100% tied to Circle's business, which spans stablecoins, digital-asset payments, and blockchain infrastructure. The fund carries a 0.75% management fee and a gross expense ratio of approximately 1.08%, and it held roughly $228 million in assets under management (AUM) as of late May 2026. This concentrated, leveraged structure means CRCA's price is essentially a magnified expression of CRCL's daily moves, which explains both its extreme volatility and its recent dramatic reversal.
CRCA's recent price action has been exceptionally volatile. Over the last 30 days, the fund climbed from a closing price of $11.88 to $24.38, a gain of roughly +105%. The move was not gradual; it followed a sharp V-shaped bottom as CRCL reversed higher off its late-July support near $59, then accelerated through mid-to-late August on a series of strong up days.
The longer view tells a different story. Approximately three months earlier, CRCA closed near $41.17, meaning the fund is still down about 41% over the last quarter even after the powerful rebound. That divergence reflects a first half of the quarter dominated by a steep decline in Circle shares, followed by a second-half recovery that has only partially retraced the drawdown. The combination of a triple-digit 30-day gain and a deep quarterly loss illustrates the outsized, trend-sensitive nature of 2x daily-reset leverage.
The 30-day surge in CRCA is primarily a leveraged reflection of Circle's own rebound. After testing support near $59 through July and early August, CRCL rallied toward the low $90s, a move of roughly 50%, and CRCA's daily 2x reset compounded that trend into a gain of more than double the underlying advance.
Several catalysts fueled the recovery in the underlying stock. Bernstein reiterated a $140 price target on Circle, arguing that its growth cycle can continue regardless of whether the CLARITY Act crypto market-structure bill passes, and pointed to renewed USDC supply growth of about $1.7 billion in a single week after months of flat circulation. Circle's Q2 2026 results, reported in early August, showed revenue of $701 million, up 7% year over year but slightly below estimates, alongside a profit beat and a sharp upward revision to full-year "other revenue" guidance tied to its Arc token pre-sale.
Broader sentiment also improved as Bitcoin strengthened and stablecoin-sector optimism returned. Cathie Wood of ARK Invest publicly defended Circle's disruption thesis, and Circle secured a federal trust bank charter from the Office of the Comptroller of the Currency, reinforcing its regulatory positioning. As the underlying momentum built, the mechanics of a leveraged daily-reset fund worked in CRCA's favor, amplifying the rally for short-term holders.
The quarterly picture is dominated by the drawdown that preceded the rebound. Circle peaked near $140 in May before a multi-month slide driven by a soft crypto market, competition from the Open USD stablecoin consortium, and uncertainty over U.S. crypto legislation. A bearish turn in analyst coverage added pressure: Morgan Stanley downgraded Circle to Underweight with a $38 target, while Mizuho kept an Underperform rating and a $45 target.
That weakness translated directly into CRCA, which fell from around $48 in mid-May to roughly $12 by early July, a decline that was compounded by the fund's 2x leverage. The subsequent August recovery has been the dominant feature of the quarter's second half, but the fund remains well below its spring levels. The quarterly trend therefore reflects a sharp industry-wide de-rating of stablecoin and digital-asset equities, followed by a sentiment-driven, catalyst-rich bounce rather than a return to prior highs.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. For high-volatility instruments such as leveraged single-stock ETFs, the platform's screening tools can help traders identify momentum shifts, breakout candidates, and sector-level trends more efficiently than manual research. Users can filter by industry, performance, and volatility to surface securities aligned with their specific strategies. Explore the AI Screener to begin building a data-driven watchlist suited to your objectives.
The factors likely to influence CRCA over the coming months are closely tied to Circle and the broader stablecoin landscape. The September 15 vote on the CLARITY Act is a key catalyst, as is the scheduled September 16 mainnet launch of Circle's Arc blockchain, which counts major financial institutions among its validators. Continued expansion of USDC circulation, transaction volumes, and the Circle Payments Network will signal whether the growth narrative holds.
Interest-rate expectations also matter, because Circle earns much of its revenue from yields on the reserves backing USDC; lower rates compress reserve income. Competitive pressure from Open USD and traditional financial institutions exploring stablecoin issuance represents an ongoing structural risk. Finally, investors should recognize the inherent mechanics of a 2x daily-reset fund: compounding and volatility decay can cause long-term returns to diverge materially from two times the underlying index over holding periods longer than a single day, making CRCA best suited for short-term, risk-aware strategies rather than passive allocation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRCA's Aroon Indicator triggered a bullish signal on September 03, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 32 similar instances where the Aroon Indicator showed a similar pattern. In of the 32 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on CRCA as a result. In of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CRCA moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CRCA crossed bullishly above the 50-day moving average on August 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in of 46 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for CRCA moved out of overbought territory on August 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 similar instances where the indicator moved out of overbought territory. In of the 2 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 9 cases where CRCA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRCA broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Category Trading